Literature DB >> 3385444

Serum antibodies to peripheral nerve tissue in acute Guillain-Barré syndrome in relation to outcome of plasma exchange.

P O Osterman1, C A Vedeler, B Ryberg, J Fagius, H Nyland.   

Abstract

Mixed haemagglutination and complement fixation tests were used to detect serum antibodies to peripheral nerve in 36 patients with acute Guillain-Barré syndrome. Twenty patients were treated with plasma exchange, 16 served as controls. A significant antibody titre was found in 19 patients with the haemagglutination test; 30 had complement-fixing antibodies. Patients lacking complement-fixing antibodies were less disabled at entry (P less than 0.01). However, there was no correlation between the course of the disease and any of the antibodies in the two patient groups. The two tests were therefore not able to select patients for treatment by plasma exchange.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3385444     DOI: 10.1007/bf00314175

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  25 in total

1.  The utility of therapeutic plasmapheresis for neurological disorders. NIH Consensus Development.

Authors: 
Journal:  JAMA       Date:  1986-09-12       Impact factor: 56.272

2.  Similarities of Fc receptors in human malignant tissue and normal lymphoid tissue.

Authors:  O Tonder; P A Morse; L J Humphrey
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

3.  Circulating demyelinating factors in acute idiopathic polyneuropathy.

Authors:  S D Cook; P C Dowling; M R Murray; J N Whitaker
Journal:  Arch Neurol       Date:  1971-02

4.  Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy.

Authors:  R J Greenwood; J Newsom-Davis; R A Hughes; S Aslan; A N Bowden; D W Chadwick; N S Gordon; D L McLellan; P Millac; R B Stott
Journal:  Lancet       Date:  1984-04-21       Impact factor: 79.321

5.  The clinical effect and the effect on serum IgG antibodies to peripheral nerve tissue of plasma exchange in patients wit Guillain-Barré syndrome.

Authors:  C A Vedeler; H Nyland; J Fagius; P O Osterman; R Matre; J A Aarli; R W Janzen; H Jacobsen; H Skre
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

6.  Guillain-Barré syndrome: quantitative measurement of plasma exchange therapy.

Authors:  M Färkkilä; E Kinnunen; E Haapanen; M Iivanainen
Journal:  Neurology       Date:  1987-05       Impact factor: 9.910

7.  Antibrain antibodies in multiple sclerosis. Relation to clinical variables.

Authors:  B Ryberg
Journal:  J Neurol Sci       Date:  1982-05       Impact factor: 3.181

8.  Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation.

Authors:  C L Koski; R Humphrey; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

9.  Endoneurial effects of sera from patients with acute inflammatory polyradiculoneuropathy: electrophysiologic studies on normal and demyelinated rat nerves.

Authors:  P A Low; J Schmelzer; P J Dyck; J J Kelly
Journal:  Neurology       Date:  1982-07       Impact factor: 9.910

10.  Clinical correlation with anti-peripheral-nerve myelin antibodies in Guillain-Barré syndrome.

Authors:  C L Koski; E Gratz; J Sutherland; R F Mayer
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.